Clinical applications of mass spectrometry‐based proteomics in cancer: Where are we?Emma L. Boys, Roger R. Reddel, Jia Liu et al.|PROTEOMICS|2022Cited by 65
Federated Deep Learning Enables Cancer Subtyping by ProteomicsZhaoxiang Cai, Alexander Swarbrick, Dylan Xavier et al.|Cancer Discovery|2025Cited by 9
Retrospective analysis of clinical characteristics and outcomes of patients with carcinoma of unknown primary from three tertiary centers in AustraliaEmma L. Boys, Jia Liu, Bo Gao et al.|Cancer Medicine|2024Cited by 8